CS-Keys Inc

CS-Keys, Inc. discovers and develops cancer-associated biomarkers using proteomics. The Company develops novel cancer diagnostic tests based on cancer associated isoform of PCNA antibody technology, as well as offers an immunohistochemistry stain for examining tissue biopsies where cancer is suspected. CS-Keys conducts business in Indianapolis, Indiana.